Lyell Immunopharma, Inc.
Key Metrics
Market Snapshot
About
Lyell Immunopharma, Inc. is a T-cell reprogramming company developing cell therapies for solid tumors. The company focuses on addressing T-cell exhaustion and enhancing the persistence and functionality of engineered T-cells for cancer treatment. Lyell combines synthetic biology and genetic reprogramming techniques to create next-generation adoptive cell therapies.